August 30, 2023
1 min watch
Save
VIDEO: Iyuzeh offers preservative free option for IOP reduction
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
MARCO ISLAND, Fla. — In this Healio Video Perspective, Monique M. Barbour, MD, MHA, FAAO, discusses why Iyuzeh is a promising new treatment for open-angle glaucoma and ocular hypertension.
“With Iyuzeh [latanoprost ophthalmic solution 0.005%], our patients are able to ensure the IOP lowering efficacy of latanoprost and the elimination of exposure to preservatives,” she said at the Women in Ophthalmology Summer Symposium.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Barbour reports having financial disclosures for Iveric Bio, Sun Pharma, Théa Pharma and Viatris.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.